Personal information

Activities

Collapse all

Works (5)

EPIGALOCATEQUINA-GALATO COMO POTENCIAL TERAPÊUTICO NO TRATAMENTO DE DOENÇAS INFLAMATÓRIAS RARAS INTRATÁVEIS

JNT - FACIT BUSINESS AND TECHNOLOGY JOURNAL
2023-03 | Journal article
DOI: 10.29327/2199304.1.40-9
Contributors: Suzana Lopes Bomfim Balaniuc
Source: Self-asserted source
Suzana Lopes Bomfim Balaniuc

Rare and intractable fibrodysplasia ossificans progressiva shows different PBMC phenotype possibly modulated by ascorbic acid and propranolol treatment

Intractable & Rare Diseases Research
2021-08-31 | Journal article
DOI: 10.5582/irdr.2021.01012
Part of ISSN: 2186-361X
Part of ISSN: 2186-3644
Contributors: Deborah Ribeiro Nascimento; Suzana Lopes Bomfim Balaniuc; Durval Batista Palhares; Adam Underwood; Marilene Garcia Palhares; Fabiana Alves; Francisco Oliveira Vieira; Elaine Maria Souza-Fagundes; Liane De Rosso Giuliani; Paula Cristhina Niz Xavier et al.
Source: Self-asserted source
Suzana Lopes Bomfim Balaniuc

CLINICAL SUSPICION OF EARLY OR LATE NEONATAL SEPSIS WITH THE USE OF PCR WITH UNIVERSAL PRIMER

2021-03 | Magazine article
Contributors: Suzana Lopes Bomfim Balaniuc
Source: Self-asserted source
Suzana Lopes Bomfim Balaniuc

FIBRODISPLASIA OSSIFICANTE PROGRESSIVA: GENES PRÓ-INFLAMATÓRIOS E PRÓ-FIBRÓTICOS COMO ALVOS DE PESQUISA E TRATAMENTO DE SINTOMAS CLÍNICOS DESTA RARA E DEVASTADORA DOENÇA

2019-07 | Journal article
Contributors: Suzana Lopes Bomfim Balaniuc
Source: Self-asserted source
Suzana Lopes Bomfim Balaniuc

Propranolol and ascorbic acid in control of fibrodysplasia ossificans progressiva flare-ups due to accidental falls

Intractable & Rare Diseases Research
2019-02-28 | Journal article
DOI: 10.5582/irdr.2018.01095
Part of ISSN: 2186-361X
Part of ISSN: 2186-3644
Contributors: Durval Batista Palhares; Deborah Ribeiro Nascimento; Marilene Garcia Palhares; Suzana Lopes Bomfim Balaniuc; Liane de Rosso Giuliani; Paula Cristhina Niz Xavier; José Mauro Goulart Brum; Fabiana Alves; Francisco Oliveira Vieira; Elaine Maria Souza-Fagundes et al.
Source: Self-asserted source
Suzana Lopes Bomfim Balaniuc
How many people are using ORCID?